Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles Argoff

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
Pain Medicine (Malden, Mass.)|December 31, 2013
NSAIDs or opioids, damned if you do, damned if you don't?: evidence-based selections to optimize therapeutic goals and minimize harmsCharles Argoff
Current Medical Research and Opinion|September 16, 2011
Mechanisms of pain transmission and pharmacologic managementCharles Argoff
Evidence-Based Medicine|March 1, 2017
Pregabalin is effective in reducing fibromyalgia painCharles Argoff
Pain Medicine (Malden, Mass.)|December 8, 2010
The emerging use of botulinum toxins for the treatment of neuropathic painCharles Argoff
Pain Medicine (Malden, Mass.)|September 25, 2012
American Academy of Pain Medicine response to PROP petition to the FDA that seeks to limit pain medications for legitimate noncancer pain sufferersPerry Fine, Lynn Webster, Charles Argoff
Current Medical Research and Opinion|October 5, 2020
When to consider "mixed pain"? The right questions can make a difference!Rainer Freynhagen, Roberto Rey, Charles Argoff
Pain Medicine (Malden, Mass.)|February 16, 2018
Small Fiber Polyneuropathy Is Prevalent in Patients Experiencing Complex Chronic Pelvic PainAnnie Chen, Elise De, Charles Argoff
PM & R : the Journal of Injury, Function, and Rehabilitation|July 25, 2009
Interpreting reviews and guidelines: the case of lumbar epidural steroid injectionsVenu Akuthota, Charles Argoff, William C Watters
Current Pain and Headache Reports|February 28, 2006
Rational multidrug therapy in the treatment of neuropathic painMisha-Miroslav Backonja, Gordon Irving, Charles Argoff
JAMA|August 9, 2018
Opioids vs Nonopioids for Chronic Back, Hip, or Knee PainEdward Covington, Charles Argoff, Steven P Stanos
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Pain Medicine (Malden, Mass.)|December 31, 2013
NSAIDs or opioids, damned if you do, damned if you don't?: evidence-based selections to optimize therapeutic goals and minimize harmsCharles Argoff
Current Medical Research and Opinion|September 16, 2011
Mechanisms of pain transmission and pharmacologic managementCharles Argoff
Evidence-Based Medicine|March 1, 2017
Pregabalin is effective in reducing fibromyalgia painCharles Argoff
Pain Medicine (Malden, Mass.)|December 8, 2010
The emerging use of botulinum toxins for the treatment of neuropathic painCharles Argoff
Pain Medicine (Malden, Mass.)|September 25, 2012
American Academy of Pain Medicine response to PROP petition to the FDA that seeks to limit pain medications for legitimate noncancer pain sufferersPerry Fine, Lynn Webster, Charles Argoff
Current Medical Research and Opinion|October 5, 2020
When to consider "mixed pain"? The right questions can make a difference!Rainer Freynhagen, Roberto Rey, Charles Argoff
Pain Medicine (Malden, Mass.)|February 16, 2018
Small Fiber Polyneuropathy Is Prevalent in Patients Experiencing Complex Chronic Pelvic PainAnnie Chen, Elise De, Charles Argoff
PM & R : the Journal of Injury, Function, and Rehabilitation|July 25, 2009
Interpreting reviews and guidelines: the case of lumbar epidural steroid injectionsVenu Akuthota, Charles Argoff, William C Watters
Current Pain and Headache Reports|February 28, 2006
Rational multidrug therapy in the treatment of neuropathic painMisha-Miroslav Backonja, Gordon Irving, Charles Argoff
JAMA|August 9, 2018
Opioids vs Nonopioids for Chronic Back, Hip, or Knee PainEdward Covington, Charles Argoff, Steven P Stanos
Pageof 6